Perfusion vector—a new method to quantify myocardial perfusion scintigraphy images: a simulation study with validation in patients
© Minarik et al. 2015
Received: 27 March 2015
Accepted: 5 August 2015
Published: 14 August 2015
The interpretation of myocardial perfusion scintigraphy (MPS) largely relies on visual assessment by the physician of the localization and extent of a perfusion defect. The aim of this study was to introduce the concept of the perfusion vector as a new objective quantitative method for further assisting the visual interpretation and to test the concept using simulated MPS images as well as patients.
The perfusion vector is based on calculating the difference between the anatomical centroid and the perfusion center of gravity of the left ventricle. Simulated MPS images were obtained using the SIMIND Monte Carlo program together with XCAT phantom. Four different-sized anterior and four lateral defects were simulated, and perfusion vector components x-, y-, and z-axes were calculated. For the patient study, 40 normal and 80 abnormal studies were included. Perfusion vectors were compared between normal and abnormal (apical, inferior, anterior, and lateral ischemia or infarction) studies and also correlated to the defect size.
For simulated anterior defects, the stress perfusion vector component on the y-axis (anterior-inferior direction) increased in proportion to the defect size. For the simulated lateral defects, the stress perfusion vector component on the x-axis (septal-lateral direction) decreased in proportion to the defect size. When comparing normal and abnormal patients, there was a statistically significant difference for the stress perfusion vector on the x-axis for apical and lateral defects; on the y-axis for apical, inferior, and lateral defects; and on the z-axis (basal-apical direction) for apical, anterior, and lateral defects. A significant difference was shown for the difference vector magnitude (stress/rest) between normal and ischemic patients (p = 0.001) but not for patients with infarction. The correlation between the defect size and stress vector magnitude was also found to be significant (p < 0.001).
The concept of the perfusion vector introduced in this study is shown to have potential in assisting the visual interpretation in MPS studies. Further studies are needed to validate the concept in patients.
KeywordsSPECT Ischemic heart disease Quantification Automated method
Myocardial perfusion scintigraphy (MPS) is a widely used diagnostic method for the management of patients with suspected or known ischemic heart disease [1–5]. Single-photon emission computed tomography (SPECT) is used to generate three-dimensional images of radioactive tracer distribution in the left ventricular myocardium.
Software packages for quantification of perfusion data and computer-aided diagnosis systems have been developed in order to make the interpretation of MPS studies more standardized, both regarding left ventricular function and regarding perfusion data. For perfusion data, a 17- or 20-segment model is often used that evaluates both the extent and severity of perfusion defects during stress and rest, generating a summed stress score (SSS) and a summed rest score (SRS). The difference (summed difference score (SDS)) indicates the degree of ischemia. However, it has been shown that there is a considerable variability in the scoring values between different software packages [6–9], and this variability will affect the calculated amount of ischemia. Therefore, the physician interpreting the study will use both visual assessment and scoring values for the determination of the localization and amount of ischemia. Visual interpretation has on the other hand been shown to be subject to rather large inter- and intra-observer variability . Hence, there is a need for new objective quantitative methods to be used in adjunct to the visual analysis to facilitate a correct diagnosis.
In this study, we have created a method that could assist the visual interpretation in MPS studies. The concept of the perfusion vector introduced here is based on the centroid. The centroid is the geometric center of gravity in a three-dimensional figure, in this case, the left ventricle. The left ventricle is outlined from SPECT images, and the anatomical and perfusion centroids are calculated. The location of the perfusion center of gravity will depend on the relative perfusion in the left ventricle. If the perfusion is normal throughout the left ventricle, the perfusion center of gravity and the anatomical centroid will be located close to each other. The difference between the anatomical and perfusion centroids is called the perfusion vector and will be small if the perfusion is normal. If the perfusion is not homogenous, the perfusion center of gravity will deviate from the anatomical centroid and this will result in a larger perfusion vector. The aim of this study was to test the concept of the perfusion vector in simulated MPS images and then to further validate the method in a clinical setting.
Perfusion vector concept
In order to mimic real measurements, the simulations were performed with enough photons to avoid Monte Carlo noise. Instead, Poisson noise was added after the simulations, corresponding to measurements with an administered activity of 600 MBq, an uptake of 1 % in the heart and where every projection was measured for 20 s. Tomographic images were then reconstructed using the ordered subset expectation maximization (OSEM) algorithm, four iterations, and eight subsets. A Gaussian post filter was applied with a full width at half maximum (FWHM) of 7 mm. Short-axis slices were created from the trans-axial slices. Scatter and attenuation corrections were not applied.
One thousand two hundred eighty-three patients referred for MPS in Malmö, Sweden, in 2007 were considered for inclusion. One of the investigators (ET) categorized all patients into the following groups: normal studies, anterior infarction, apical infarction, lateral infarction, inferior infarction, anterior ischemia, apical ischemia, lateral ischemia, inferior ischemia, mixed defects, multiple defects, equivocal studies, and stress-only studies. The categorization was based on visual assessment of the MPS images. Patients with mixed defects, multiple defects, equivocal studies, and stress-only studies were excluded since well-defined defects were desirable in this first patient study. The first 10 patients (40 for normal studies) to be included in the categories were used as the study population. Thus, 80 abnormal and 40 normal studies were included. EXINI Heart™ (EXINI Diagnostics AB, Lund, Sweden) was used to automatically derive the size of ischemia and infarction for all patients based on their artificial neural network algorithm. The study was approved by the local research ethics committee at Lund University and complies with the Declaration of Helsinki.
The MPS studies were performed using a 2-day gated stress/non-gated rest Tc-99m-tetrofosmin protocol, starting with injection of 600 MBq Tc-99m-tetrofosmin at stress, followed by 600 MBq Tc-99m-tetrofosmin at rest. Patients were stressed using either maximal exercise on an ergometer or pharmacological test with adenosine.
Stress and rest acquisitions began about 60 min after the injection of Tc-99m-tetrofosmin. Images were obtained according to established clinical protocols, using SPECT over 180° elliptical and autocontour rotations from the 45° right anterior oblique position, with a dual-head gamma camera, e.cam (Siemens AG Medical Solutions, Erlangen, Germany). Patients were imaged in the supine position. Low-energy high-resolution collimator and a zoom factor of 1.0 were used. We obtained 64 projections in a 128 × 128 matrix, with an acquisition time of 25 s per projection. Tomographic reconstruction and calculation of short- and long-axis slice images were performed using e.soft (Siemens AG Medical Solutions, Erlangen, Germany). Images were reconstructed with filtered back projection. A two-dimensional Butterworth pre-reconstruction filter was used with cut-off frequency of 0.45, order 5.
Kruskal-Wallis analyses were performed to investigate differences in perfusion centroids between the normal and abnormal patients. When significance was found, Mann-Whitney analyses were carried out to test for differences. Abnormal patients were compared to the normal patients; thus, multiple tests were performed. We used a Bonferroni correction to give a significance level of 0.0125 when four groups were tested and 0.025 when two tests were carried out. Spearman’s correlation test was performed to investigate differences between defect extent and magnitude vector. All analyses were carried out using MedCalc v 12.7.7 (MedCalc Software bvba, Ostend, Belgium).
In the normal patient group, there were 10 men and 30 women. Mean age was 59.3 years (range 35–88 years). For the abnormal patients, 54 men and 26 women were included. Mean age was 65.2 years (range 41–83 years). Mean total extent of defects (automatically derived from EXINI Heart™) was 0.17 % for normal patients (range 0–6.6 %) and 25.0 % (range 0 to 64.4 %) for abnormal patients. For ischemic patients, the mean extent of ischemia was 15.6 % (range 0–37.4 %), and for infarcted patients, the mean extent of infarction was 29.8 % (range 0–64.0 %).
Every day, physicians in radiology and nuclear medicine are faced with interpreting challenging studies. In medical imaging, visual interpretation of images is dependent on the knowledge of the physician and is subject to inter- and intra-observer variabilities. There is a strong need for the development of automatic, quantitative measurements to be used in addition to the visual interpretation in order to help standardize interpretation and facilitate a correct diagnosis.
In this study, we wanted to develop an automatic, quantitative measurement in MPS studies, which could assist the visual interpretation. We therefore introduced the concept of perfusion vector, based on the difference between the anatomical and perfusion-weighted centroid. Based on the simulation studies, we found that for anterior defects, the perfusion vector changed in the anterior-inferior direction, in proportion to the size of the defect. For the lateral defects, the perfusion vector changed in the septal-lateral direction, in proportion to the defect size.
After these encouraging simulation results, we wanted to validate the method in a patient population. The stress perfusion vector changed drastically for the patients with lateral defects on the x-axis, as expected. The vector for the apical defects (which often is oriented towards the septal-anterior part of the left ventricle) changed in the opposite direction. For the y-axis, the change of the perfusion vector for the inferior defects was oriented in the opposite direction compared to anterior defects (not statistically significant compared to normal patients). We found a significant difference also for patients with apical defects and lateral defects. Lateral defects are often located slightly in the inferior part of the left ventricle and apical defects often slightly in the anterior part of the left ventricle, which could explain these results. Finally, for the z-axis, as expected, the perfusion vector for the apical defects was significantly different from the normal patients. The change in perfusion vector on the z-axis for the anterior, inferior, and lateral defects will depend on if the defects are located in the basal or apical part of the left ventricle. Patients with apical defects were included as a separate group (although often located towards the anterior part of the left ventricle) in order to see if changes in the z-axis were present.
The difference (stress/rest) vector could be used to differentiate between patients with and without ischemia, but there was a large inter-individual variability. The vector magnitude correlated quite well with the automatically derived extent of the defects.
There are several possible reasons for the large inter-individual variability in the abnormal patients. The patients were selected only based on the main localization of the defect, not based on the size of the perfusion defects. Therefore, both small, medium-sized and large defects are included in the material, and the mean defect size is likely to be different for different groups. Also, patients tend not to have “perfect” distribution of tracer in areas without perfusion defects. For example, if the delineation of one part of the ventricle is slightly outside the ventricle border, there is a lower uptake in one (or more) of the basal part(s) of the ventricle, which affects the calculated perfusion vector.
The most encouraging result from the patient study was the small variation in all three orientations for the normal patients compared to the abnormal patients. It is possible that the method could be useful for the determination if a study is normal. This could for example facilitate the determination if a rest study is needed after a stress study, but this needs to be further tested. In this study, no attenuation-corrected images were studied. It is unknown how the perfusion vector method works in attenuation-corrected images, but one hypothesis is that the variation in different orientations for the normal patients will be even smaller due to a more homogenous tracer uptake in attenuation-corrected images. An advantage of the perfusion vector concept is that the method is fully automated and thus eliminates subjective assessment of the images.
For the normal group, we used patients that were admitted for clinical MPS due to suspicion of coronary artery disease but were interpreted as normal. It would be preferred to use a normal population, with a low likelihood of coronary artery disease. Only a limited number of patients with ischemia and infarction were included. We also do not have any other method, such as invasive coronary angiography with fractional flow reserve measurements, to validate the interpretation of SPECT images.
The concept of the perfusion vector introduced in this study is shown to have potential in assisting the visual interpretation in MPS studies. The small variation in normal patients compared to the abnormal patients could prove to be helpful to determine if a study is to be considered normal and without perfusion defects. For the abnormal studies, there was a gradual change of the perfusion vector correlating to the size of the perfusion defect, both in simulated images and in patient studies. Hence, here, the perfusion vector could assist when assessing the size of a perfusion defect. Further studies are needed to validate the concept in patients.
This work was supported by grants provided by agreement on medical training and clinical research (ALF) between Skåne County Council and Lund University.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;97(6):535–43.View ArticlePubMedGoogle Scholar
- Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation. 1996;93(5):905–14.View ArticlePubMedGoogle Scholar
- Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J. 2011;32(8):1012–24. doi:10.1093/eurheartj/ehq500.View ArticlePubMedGoogle Scholar
- Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol. 1998;32(1):57–62.View ArticlePubMedGoogle Scholar
- Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging. 2004;31(2):261–91. doi:10.1007/s00259-003-1344-5.PubMed CentralView ArticlePubMedGoogle Scholar
- Johansson L, Lomsky M, Marving J, Ohlsson M, Svensson SE, Edenbrandt L. Diagnostic evaluation of three cardiac software packages using a consecutive group of patients. EJNMMI Res. 2011;1(1):22. doi:10.1186/2191-219X-1-22.PubMed CentralView ArticlePubMedGoogle Scholar
- Guner LA, Karabacak NI, Cakir T, Akdemir OU, Kocaman SA, Cengel A, et al. Comparison of diagnostic performances of three different software packages in detecting coronary artery disease. Eur J Nucl Med Mol Imaging. 2010;37(11):2070–8. doi:10.1007/s00259-010-1522-1.View ArticlePubMedGoogle Scholar
- Wolak A, Slomka PJ, Fish MB, Lorenzo S, Acampa W, Berman DS, et al. Quantitative myocardial-perfusion SPECT: comparison of three state-of-the-art software packages. J Nucl Cardiol. 2008;15(1):27–34. doi:10.1016/j.nuclcard.2007.09.020.View ArticlePubMedGoogle Scholar
- Svensson A, Akesson L, Edenbrandt L. Quantification of myocardial perfusion defects using three different software packages. Eur J Nucl Med Mol Imaging. 2004;31(2):229–32. doi:10.1007/s00259-003-1361-4.View ArticlePubMedGoogle Scholar
- Edenbrandt L, Hoglund P, Frantz S, Hasbak P, Johansen A, Johansson L, et al. Area of ischemia assessed by physicians and software packages from myocardial perfusion scintigrams. BMC Med Imaging. 2014;14(1):5. doi:10.1186/1471-2342-14-5.PubMed CentralView ArticlePubMedGoogle Scholar
- Ljungberg M, Strand SE. A Monte Carlo program for the simulation of scintillation camera characteristics. Comput Methods Programs Biomed. 1989;29(4):257–72.View ArticlePubMedGoogle Scholar
- Segars WP, Sturgeon G, Mendonca S, Grimes J, Tsui BM. 4D XCAT phantom for multimodality imaging research. Med Phys. 2010;37(9):4902–15.PubMed CentralView ArticlePubMedGoogle Scholar